Equities

Jiangsu Nanfang Medical Co Ltd

603880:SHH

Jiangsu Nanfang Medical Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)3.55
  • Today's Change0.09 / 2.60%
  • Shares traded2.40m
  • 1 Year change-35.57%
  • Beta0.9422
Data delayed at least 15 minutes, as of Apr 18 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Jiangsu Nanfang Medical Co., Ltd. is a China-based company which is mainly engaged in manufacture and sales of medical dressings and pharmaceutical products. The Company is mainly engaged in research and development, manufactures and sales of transdermal products, medical tape and bandages, sports protection products, first-aid kits, nursing products and others. The Company’s main products include Band-Aid, patches, medical tapes, plaster dressings, sports protection products, first-aid kits, care products and other products. The Company’s brands include MIAO-SHOU, Oushun and others.

  • Revenue in CNY (TTM)600.10m
  • Net income in CNY-147.42m
  • Incorporated1990
  • Employees858.00
  • Location
    Jiangsu Nanfang Medical Co LtdNo.1 Guoxiang RoadWujin Economic Development ZoneCHANGZHOU ChinaCHN
  • Phone+86 51 986361837
  • Fax+86 51 986363601
  • Websitehttps://www.nfmedical.com.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Jiangsu Nanfang Medical Co Ltd600.10m-147.42m1.12bn858.00--2.35--1.86-0.5102-0.51022.081.620.43891.984.47699,411.80-10.77-1.09-26.18-2.008.1120.14-24.54-1.910.3813-10.530.5156--10.034.57-906.35---3.18--
CareRay Digital Medical Technology CoLtd276.59m23.25m1.14bn252.0048.861.33--4.110.26380.26383.149.700.30371.474.511,097,595.002.566.652.737.3739.8441.178.4115.6411.20--0.00627.6133.815.17374.05-20.7477.38--
Touchstone International Medi Sci Co Ltd245.46m44.51m1.37bn231.0030.362.39--5.590.55710.55713.077.070.4263.0646.291,062,615.007.7311.598.3612.5653.7558.1718.1320.5013.22--0.004127.858.5620.954.2925.4425.67--
Thalys Medical Technology Group Corp2.08bn-153.22m1.46bn1.47k--1.06--0.7022-0.7571-0.757110.276.850.52333.421.171,408,150.00-4.790.6724-9.091.1917.7523.85-9.151.091.43-1.120.4564302.10-11.1920.19-211.92---13.98--
HOB Biotech Group Corp Ltd365.94m35.81m1.57bn488.0043.951.96--4.300.56790.56795.8012.710.39691.508.54749,886.803.8813.034.4816.3960.6267.069.7921.841.88--0.082824.700.844916.97-51.6814.3060.28--
Guangzhou Jet Bio-Filtration Co Ltd463.10m34.79m1.67bn1.09k48.141.45--3.620.24780.24783.308.240.28663.143.98424,470.802.179.352.3410.3929.1636.767.5817.896.648.010.227129.64-24.0617.42-60.34-8.0247.32--
Allgens Medical Technology Co Ltd-100.00bn-100.00bn1.92bn151.00--1.38----------10.47------------------------35.91--0.0354--3.92---21.17------
Data as of Apr 18 2024. Currency figures normalised to Jiangsu Nanfang Medical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Taiping Fund Management Co., Ltd.as of 30 Jun 20230.000.00%
Data from 30 Jun 2023 - 30 Jun 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.